Cassava Sciences, Inc. (SAVA)
2.19
-0.13
(-5.60%)
USD |
NASDAQ |
Jan 23, 16:00
2.19
0.00 (0.00%)
After-Hours: 17:15
Cassava Sciences Research and Development Expense (TTM): 43.27M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| cbdMD, Inc. | -- |
| BioMarin Pharmaceutical, Inc. | 682.06M |
| Amicus Therapeutics, Inc. | 142.29M |
| Geron Corp. | 81.32M |
| NovaBay Pharmaceuticals, Inc. | -- |